Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...

When Michelle Gidion first noticed the blue bruises dotted across her lower legs, she put them down to the family dog bashing ...

in a Chinese PD-L1-positive non-small cell lung cancer (NSCLC) population. That led some market observers to predict the drug could become a 'Keytruda killer' and potentially a replacement for ...